share_log

British American Tobacco | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

SEC ·  Feb 16 19:06

Summary by Moomoo AI

B.A.T Capital Corporation, a subsidiary of British American Tobacco, has announced the pricing of two series of notes on February 15, 2024. The offering includes $850 million of 5.834% notes due in 2031 and $850 million of 6.000% notes due in 2034. The notes are senior and unsubordinated, with interest payments to be made semi-annually. The 2031 Notes and 2034 Notes are priced at 100.000% and 99.437% of their principal amounts, respectively, with net proceeds before expenses totaling approximately $847 million for the 2031 Notes and $842 million for the 2034 Notes. The notes are expected to settle on February 20, 2024, and have been rated Baa2 by Moody's, BBB+ by S&P, and BBB by Fitch. The offering is registered with the SEC and the notes will be listed on the New York Stock Exchange, subject to approval. Barclays Capital Inc., HSBC Securities (USA) Inc., and other financial institutions are managing the book-running.
B.A.T Capital Corporation, a subsidiary of British American Tobacco, has announced the pricing of two series of notes on February 15, 2024. The offering includes $850 million of 5.834% notes due in 2031 and $850 million of 6.000% notes due in 2034. The notes are senior and unsubordinated, with interest payments to be made semi-annually. The 2031 Notes and 2034 Notes are priced at 100.000% and 99.437% of their principal amounts, respectively, with net proceeds before expenses totaling approximately $847 million for the 2031 Notes and $842 million for the 2034 Notes. The notes are expected to settle on February 20, 2024, and have been rated Baa2 by Moody's, BBB+ by S&P, and BBB by Fitch. The offering is registered with the SEC and the notes will be listed on the New York Stock Exchange, subject to approval. Barclays Capital Inc., HSBC Securities (USA) Inc., and other financial institutions are managing the book-running.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more